An eco-friendly HPLC method for simultaneous analysis of sildenafil and sodium benzoate in pulmonary arterial hypertension suspension dosage monitoring
Abstract
The purpose of this research is to develop a fast, environmentally friendly, precise, sensitive, and specific high-performance liquid chromatography (HPLC) method for the simultaneous determination of sildenafil and sodium benzoate in bulk raw materials and in the legally marketed reference drug (Revatio powder for oral suspension). The optimized mobile phase flow rate was 1 mL/min, with the mobile phase consisting of 600 mL of 0.2% v:v phosphoric acid aqueous solution and 400 mL of ethyl alcohol. The range of linearity used for sildenafil and sodium benzoate was 3.5-280 µg/mL (sildenafil) and 0.35-28 µg/mL (sodium benzoate), respectively. The wavelength used to analyze the samples was 230 nm; the sample size was 10 µL; and the analysis time was less than 4.5 min. The ultimate scores are as follows: 0.63 for the Analytical Greenness Metric for Sample Preparation (AGREEprep), 72.22 for the Analytical Green Star Area (AGSA), 80 for the Blue Applicability Grade Index (BAGI), 72 for the Click Analytical Chemistry Index (CACI), 88 for the Carbon Footprint Reduction Index (CaFRI), 89 for the Analytical Ecoscale (AES), and 78 for the Modified Green Analytical Procedure Index (MoGAPI), and an (A) letter score of 75.3% indicates the whiteness level using the Multi-color Assessment (MA) Tool, and all imply the high sustainability, greenness, whiteness, and economic wisdom of the current method. All validation characteristics have followed the International Council for Harmonisation…
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.